Vioxx Withdrawal Raises Concern About FDA
119747
Americans should feel reasonably safe taking government-approved prescription drugs - with a few caveats - even after a popular arthritis medication was pulled from the market, medical experts say. But the problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug, observers say...
284993
Doctors have been taking calls from anxious patients ever since a Senate hearing on Vioxx last week at which an FDA scientist expressed concerns about the safety of five other drugs on the market.
81161
Drug giant Merck pulled its painkiller Vioxx because it increased the risk of heart attacks and strokes. Now the company may face thousands of lawsuits.
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
130636
The furor over the safety of arthritis painkilling medications shows no sign of abating. Vioxx is gone from the market, following data linking it to increased cardiovascular risk.
60804
Two years after the withdrawal of the painkiller Vioxx, a dysfunctional Food and Drug Administration still can't adequately track the safety of new drugs and respond quickly to problems, a panel of experts said Friday.
80277
The arthritis drug Vioxx, used by  millions of people around the world, is being pulled off the  market after a study confirmed long-standing concerns that it  raises the risk of heart attack and stroke, the manufacturer,  Merck & Co. MRK.N, said on Thursday.
115447
The FDA (USA) says it did not try to suppress the findings of a safety official regarding the Vioxx painkiller. Vioxx was taken off the market last week because the drug increases a patient&#39;s risk of having a heart attack.
643175
Now that Merck has removed Vioxx from the market, drugs in the same class - both available and awaiting approval - are undergoing renewed scrutiny.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
472146
WASHINGTON - Congress is looking into whether the Food and Drug Administration shirked its duty by ignoring safety concerns about Vioxx raised by its own reviewers and outside scientists.
49935
Description: A voluntary withdrawal of Vioxx from the market is the latest in a string of safety issues for the drug market. Dr. Alistair Wood, of the Vanderbilt School of Medicine, says the serious dangers
140672
WASHINGTON - The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck & Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes, the chairman of the Senate Finance Committee said Thursday...
433075
When pharmaceutical giant Merck &amp; Co. abruptly pulled its arthritis pain medication Vioxx from the marketplace on Sept. 30, more than 2 million patients were taking the drug.
319259
The recent Vioxx withdrawal and testimony from an FDA insider accusing the agency of failing to protect public health are fueling such heightened
346665
Doctors were bombarded with phone calls from worried patients following the announcement last week that drug manufacturer Merck had pulled its popular arthritis drug, Vioxx, from the market because of safety concerns.
306536
TORONTO (CP) - In the wake of last week&#39;s surprise market withdrawal of wonder drug Vioxx, scientists Wednesday questioned the safety of the entire class of arthritis drugs known as Cox-2 inhibitors.